Repository logo
 
Loading...
Thumbnail Image
Publication

Caffeoylquinic acids as inhibitors for HIV-I protease and HIV-I integrase: a molecular docking study

Use this identifier to reference this record.

Advisor(s)

Abstract(s)

Caffeoylquinic acids are ubiquitous phenolic compounds with several health benefits to humans and they have been shown to be promisinganti-HIV compounds. In this work, molecular docking was used to study the inhibition of HIV-I integrase and protease using caffeoylquinic acids. It was possible to establish that the naturally occurring caffeoylquinic acids are not suitable as inhibitors for protease but are very good inhibitors for integrase. A new binding site was found for 3, 4-O-di-Caffeoylquinic acid between the chains of HIV-I integrase that could possibly lead to a disruption of the catalytic process of HIV-I integrase.

Description

Keywords

HIV Integrase Protease Molecular docking In silico Caffeoylquinic acid Enzyme inhibition . Faculdade de Ciências Exatas e da Engenharia

Citation

Serina, J. C., Castilho, P. C., Fernandes, M. X., & Desk, S. (2016). Caffeoylquinic acids as inhibitors for HIV-I protease and HIV-I Integrase. A Molecular docking study. SDRP Journal of Computational Chemistry & Molecular Modelling, 1(2).

Research Projects

Organizational Units

Journal Issue

Publisher

Sift Desk Journals